title: Tacrolimus in refractory polymyositis with interstitial lung disease.
authors.forename: C V
authors.initials: CV
authors.lastname: Oddis
authors.forename: F C
authors.initials: FC
authors.lastname: Sciurba
authors.forename: K A
authors.initials: KA
authors.lastname: Elmagd
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D018737:Hand Strength; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017563:Lung Diseases, Interstitial / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D017285:Polymyositis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D007166:Immunosuppressive Agents; D003402:Creatine Kinase; D016559:Tacrolimus